A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Mirabello, Lisa ^a   Yu, Kai ^a   Berndt, Sonja I ^a   Burdett, Laurie ^b   Wang, Zhaoming ^b   Chowdhury, Salma ^b   Teshome, Kedest ^b   Uzoka, Arinze ^b   Hutchinson, Amy ^b   Grotmol, Tom ^c   Douglass, Chester ^d   Hayes, Richard B ^e   Hoover, Robert N ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE GROWTH; CANCER RISK; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; FANCM GENE; FEMALE; FIBROBLAST GROWTH FACTOR 2 GENE; FIBROBLAST GROWTH FACTOR RECEPTOR 3 GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GONADOTROPIN RELEASING HORMONE 2 GENE; GROWTH HORMONE 1 GENE; HORMONE METABOLISM; HUMAN; INSULIN LIKE GROWTH FACTOR 1 GENE; MALE; MDM2 GENE; N METHYLPURINE DNA GLYCOSYLASE GENE; OSSIFICATION; OSTEOSARCOMA; RIBOSOME; SCHOOL CHILD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; ADOLESCENT; BONE TUMOR; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; OSTEOSARCOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79960137500     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-209     Document Type: Article

References (49)

1. Mirabello L, Troisi R, Savage S. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009, 115(7):1531-1543. 10.1002/cncr.24121, 2813207, 19197972.
2. Mirabello L, Troisi R, Savage S. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009, 125(1):229-234. 10.1002/ijc.24320, 3048853, 19330840.
3. Fraumeni JJ, Boice J. Bone. Cancer Epidemiology and Prevention 1982, Philadelphia: W B Saunders Co, Schottenfeld D FJJ.
4. Fraumeni JJ. Stature and malignant tumors of the bone in childhood and adolescence. Cancer 1967, 20:967-973. 10.1002/1097-0142(196706)20:6<967::AID-CNCR2820200606>3.0.CO;2-P, 5229526.
5. Scranton P, DeCicco F, Totten R, Yunis E. Prognostic factors in osteosarcoma. A review of 20 years' experience at the University of Pittsburgh Health Center Hospitals. Cancer 1975, 36:2179-2191. 10.1002/cncr.2820360936, 1060506.
6. Gelberg K, Fitzgerald E, Hwang S, Dubrow R. Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol 1997, 26:272-278. 10.1093/ije/26.2.272, 9169161.
7. Rytting M, Pearson P, Raymond A, Ayala A, Murray J, Yasko A, Johnson M, Jaffe N. Osteosarcoma in preadolescent patients. Clin Orthop Relat Res 2000, 373:39-50.
8. Ruza E, Sotillo E, Sierrasesúmaga L, Azcona C, Patiño-Garcia A. Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 2003, 25:780-786. 10.1097/00043426-200310000-00007, 14528100.
9. Cotterill S, Wright C, Pearce M, Craft A. Stature of young people with malignant bone tumors. Pediatr Blood Cancer 2004, 42:59-63. 10.1002/pbc.10437, 14752796.
10. Longhi A, Pasini A, Cicognami A, Baronio F, Pellacani A, Baldini N, Bacci G. Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 2005, 27:314-318. 10.1097/01.mph.0000169251.57611.8e, 15956884.
11. Goodman M, McMaster J, Drash A, Diamond P, Kappakas G, Scranton PJ. Metabolic and endocrine alterations in osteosarcoma patients. Cancer 1978, 42:603-610. 10.1002/1097-0142(197808)42:2<603::AID-CNCR2820420229>3.0.CO;2-6, 277283.
12. Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patiño-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schüz J, Craft AW, et al. Meta-analysis of height at diagnosis and birth-weight as osteosarcoma risk factors. in submission.
13. Varley J. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003, 21:313-320. 10.1002/humu.10185, 12619118.
14. Chauveinc L, Mosseri V, Quintana E, Desjardins L, Schlienger P, Doz F, Dutrillaux B. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 2001, 22:77-88. 10.1076/opge.22.2.77.2228, 11449317.
15. Kansara M, Thomas D. Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007, 26:1-18. 10.1089/dna.2006.0505, 17263592.
16. Lipton J, Federman N, Khabbaze Y, Schwartz C, Hilliard L, Clark J, Vlachos A. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol 2001, 23:39-44. 10.1097/00043426-200101000-00009, 11196268.
17. Hanson MFSM, Merchant A. Osteosarcoma in Paget's disease of bone. Journal of bone and mineral research 2006, 21(S2):P58-P63. 10.1359/jbmr.06s211, 17229010.
18. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, Sierrases-Maga L. Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J Med Genet 2000, 37:789-792. 10.1136/jmg.37.10.789, 1757156, 11183184.
19. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, . The National Osteosarcoma Etiology Study Group Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 2007, 16:1667-1674. 10.1158/1055-9965.EPI-07-0214, 17684144, The National Osteosarcoma Etiology Study Group.
20. Koshkina N, Kleinerman E, Li G, Zhao C, Wei Q, Sturgis E. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J Pediatr Hematol Oncol 2007, 29:815-821. 10.1097/MPH.0b013e3181581506, 18090928.
21. Hu Y, Pan Y, Li W, Zhang Y, Li J, Ma B. Association between TGFBR1*6A and osteosarcoma: A Chinese case-control study. BMC Cancer 2010, 10(1):169. 10.1186/1471-2407-10-169, 2875216, 20429896.
22. Toffoli G, Biason P, Russo A, De Mattia E, Cecchin E, Hattinger C, Pasello M, Alberghini M, Ferrari C, Scotlandi K, et al. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res 2009, 15:3550-3556. 10.1158/1078-0432.CCR-08-2249, 19451596.
23. Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 2007, 49:28-33. 10.1002/pbc.21077, 17096406.
24. Kappel C, Velez-Yanguas M, Hirschfeld S, Helman L. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 1994, 54:2803-2807.
25. Pollak M, Schernhammer E, Hankinson S. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004, 4:505-518. 10.1038/nrc1387, 15229476.
26. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 2003, 145:1-30. 10.1016/S0165-4608(03)00105-5, 12885459.
27. Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, Squire JA. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet 2003, 144:91-99. 10.1016/S0165-4608(02)00929-9, 12850370.
28. Shimamura A, Alter B. Pathophysiology and Management of Inherited Bone Marrow Failure Syndromes. Blood Reviews 2010,
29. Troisi R, Masters M, Joshipura K, Douglass C, Cole B, Hoover R. Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 2006, 95:1603-1607. 10.1038/sj.bjc.6603474, 2360735, 17106438.
30. Yu K, Li Q, Bergen A, Pfeiffer R, Rosenberg P, Caporaso N, Kraft P, Chatterjee N. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009, 33:700-709. 10.1002/gepi.20422, 2790032, 19333968.
31. Barrett J, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
32. Glass AGFJ. Epidemiology of bone cancer in children. J Natl Cancer Inst 1970, 44:187-199.
33. Miller R. Contrasting epidemiology of childhood osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr 1981, 56:9-15.
34. Ruddon R. Cancer Biology. 2007, New York: Oxford University Press, Inc, 4.
35. Gari K, Décaillet C, Stasiak A, Stasiak A, Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol Cell 2008, 29:141-148. 10.1016/j.molcel.2007.11.032, 18206976.
36. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I, Mathew CG, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 2005, 37:958-963. 10.1038/ng1626, 2704909, 16116422.
37. Hoeijmakers J. DNA damage, aging, and cancer. N Engl J Med 2009, 361:1475-1485. 10.1056/NEJMra0804615, 19812404.
38. Burrow S, Andrulis I, Pollak M, Bell R. Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma. J Surg Oncol 1998, 69:21-27. 10.1002/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO;2-M, 9762887.
39. McCarthy T, Centrella M. Local IGF-I expression and bone formation. Growth Horm IGF Res 2001, 11:213-219. 10.1054/ghir.2001.0236, 11735236.
40. Conover C. Insulin-like growth factor-binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 2008, 294:E10-14.
41. Pollak M, Sem A, Richard M, Tetenes E, Bell R. Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J Natl Cancer Inst 1992, 84:966-971. 10.1093/jnci/84.12.966, 1321252.
42. Kappel C, Velez-Yanguas M, Hirschfeld S, Helman L. Human osteosarcoma cell lines are dependent on insulinlike growth factor I for in vitro growth. Cancer Res 1994, 54:2803-2807.
43. Pinski J, Schally A, Groot K, Halmos G, Szepeshazi K, Zarandi M, et al. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst 1995, 87:1787-1794. 10.1093/jnci/87.23.1787, 7473836.
44. Withrow S, Powers B, Straw R, RM W. Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res 1991, 270:159-168.
45. Tjalma R. Canine bone sarcoma: Estimation of relative risk as a function of body size. J Natl Cancer Inst 1966, 36:1137-1150.
46. Sutter N, Bustamante C, Chase K, Gray M, Zhao K, Zhu L, Padhukasahasram B, Karlins E, Davis S, Jones P, et al. A single IGF1 allele is a major determinant of small size in dogs. Science 2007, 316:112-115. 10.1126/science.1137045, 2789551, 17412960.
47. Strahm B, Malkin D. Mini Review: Hereditary cancer predisposition in children: Genetic basis and clinical implications. Int J Cancer 2006, 119(2001-2006).
48. Lindor N, McMaster M, Lindor C, Greene M, . National Cancer Institute DoCP, Community Oncology and Prevention Trials Research Group Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition. JNCI Monographs 2008, 38:1-93. National Cancer Institute DoCP, Community Oncology and Prevention Trials Research Group.
49. Daroszewska A, Ralston S. Genetics of Paget's disease of bone. Clin Sci (Lond) 2005, 109:257-263.